Mersana Therapeutics, Inc. Short-term Debt
Mersana Therapeutics, Inc. had Short-term Debt of $2.08 million as of 2023-12-31, per its 10-K filed 2024-02-28.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ShortTermBorrowings · last filed 2024-02-28
- 2023-12-31: Short-term Debt $2.08M.
- 2022-12-31: Short-term Debt $0.00.
| Period end | Short-term Debt |
|---|---|
| 2023-12-31 | $2.08M 10-K · filed 2024-02-28 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |